New Consensus Outlines Best Practices for Obesity Medications

New consensus outlines best practices for obesity medications

Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding use of obesity drugs for weight loss treatment.

Obesity and Dietitian Groups Release Guidelines on Incretin Drug Use

Obesity treatment has entered a transformative era with the rise of incretin-based therapies (IBTs), notably GLP-1 receptor agonists, which have redefined weight management strategies. Yet, with these advancements come multifaceted challenges spanning nutritional, psychological, and functional domains. A landmark consensus statement, recently published in The Lancet Diabetes & Endocrinology by Dr. Laurence Dobbie and collaborators from major Eur…